MarketCap
Facebook
X
Telegram
Ampio Pharmaceuticals Langfristiger Schuldenstrom | AMPE
Langfristiger Schuldenstrom Jährlich Ampio Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 274 K | 340 K | 311 K | 284 K | 259 K | 60 K | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 340 K | 60 K | 255 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aurinia Pharmaceuticals
AUPH
|
1.07 M | $ 16.3 | -1.93 % | $ 2.19 B |  Canada |
 |
Cullinan Management
CGEM
|
780 K | $ 11.34 | -3.32 % | $ 683 M |  USA |
 |
BioNTech SE
BNTX
|
45 M | $ 87.2 | -0.36 % | $ 21.1 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
1.41 M | $ 24.47 | -0.97 % | $ 775 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
1.63 M | $ 3.95 | 12.07 % | $ 52.6 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
235 K | $ 1.21 | -11.68 % | $ 55.3 M |  Israel |
 |
AnaptysBio
ANAB
|
2.16 M | $ 48.4 | 0.9 % | $ 1.4 B | USA |
 |
Assembly Biosciences
ASMB
|
569 K | $ 21.33 | -2.11 % | $ 239 M | USA |
 |
Adagene
ADAG
|
92.1 K | $ 2.02 | -4.95 % | $ 119 M |  China |
 |
Benitec Biopharma
BNTC
|
496 K | $ 9.31 | -5.67 % | $ 433 M | USA |
 |
Denali Therapeutics
DNLI
|
9.46 M | $ 19.85 | -2.36 % | $ 3.43 B | USA |
 |
Amarin Corporation plc
AMRN
|
2.15 M | $ 11.75 | 0.09 % | $ 4.88 B |  Irlanda |
 |
ImmuCell Corporation
ICCC
|
85.5 K | $ 10.4 | 1.76 % | $ 93.9 M | USA |
 |
Editas Medicine
EDIT
|
6.03 M | $ 2.5 | -9.09 % | $ 222 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
18.4 M | $ 31.77 | 1.23 % | $ 1.84 B | USA |
 |
Cue Biopharma
CUE
|
1.91 M | $ 18.89 | -6.21 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
363 K | $ 1.45 | -3.33 % | $ 83.1 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
3.71 M | $ 1.6 | -14.05 % | $ 91 M | USA |
 |
Abeona Therapeutics
ABEO
|
864 K | $ 2.46 | -3.35 % | $ 130 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
11.6 M | $ 18.13 | 9.85 % | $ 3.05 B | USA |
 |
Atossa Therapeutics
ATOS
|
18.1 K | $ 2.21 | 3.76 % | $ 19 M | USA |
 |
ADC Therapeutics SA
ADCT
|
538 K | $ 1.51 | -9.88 % | $ 192 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
1.07 M | $ 33.57 | -0.62 % | $ 1.93 B | USA |
 |
Ardelyx
ARDX
|
1.48 M | $ 3.0 | 2.39 % | $ 723 M | USA |
 |
Akebia Therapeutics
AKBA
|
3.55 M | $ 0.54 | 1.8 % | $ 139 M | USA |
 |
Alector
ALEC
|
9.06 M | $ 2.54 | 3.05 % | $ 262 M | USA |
 |
ALX Oncology Holdings
ALXO
|
901 K | $ 1.11 | -13.62 % | $ 59.6 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
6.76 M | $ 21.39 | 0.52 % | $ 6.7 B | USA |
|
Phathom Pharmaceuticals
PHAT
|
648 K | $ 5.45 | 2.16 % | $ 397 M | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
547 K | $ 3.8 | 2.15 % | $ 728 M | Canada |
 |
Agenus
AGEN
|
1.03 M | $ 7.02 | -1.82 % | $ 209 M | USA |
 |
AbCellera Biologics
ABCL
|
5.82 M | $ 12.44 | -0.52 % | $ 3.72 B | Canada |
 |
Artelo Biosciences
ARTL
|
40 K | $ 2.14 | 2.01 % | $ 405 K | USA |
|
Immatics N.V.
IMTX
|
2.76 M | $ 6.42 | -0.23 % | $ 785 M | Germany |
 |
Aptevo Therapeutics
APVO
|
866 K | $ 1.08 | -4.42 % | $ 341 K | USA |
 |
Aligos Therapeutics
ALGS
|
3.58 M | $ 2.59 | -34.43 % | $ 25.6 M | USA |
 |
Aclaris Therapeutics
ACRS
|
551 K | $ 4.13 | -2.5 % | $ 506 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
8.92 M | $ 29.38 | -2.91 % | $ 4.46 B | USA |
 |
Cellectar Biosciences
CLRB
|
100 K | $ 1.24 | -3.15 % | $ 3.23 M | USA |
|
Larimar Therapeutics
LRMR
|
1.1 M | $ 2.68 | 5.93 % | $ 223 M | USA |
 |
Pliant Therapeutics
PLRX
|
1.45 M | $ 0.78 | -2.19 % | $ 47.9 M | USA |
 |
Pharming Group N.V.
PHAR
|
1.6 M | $ 13.02 | -1.06 % | $ 8.97 B |  Niderland |
 |
Capricor Therapeutics
CAPR
|
202 K | $ 8.91 | -9.54 % | $ 414 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
7.93 M | $ 29.06 | -1.09 % | $ 1.36 B | USA |
 |
Aquestive Therapeutics
AQST
|
631 K | $ 3.52 | -0.56 % | $ 376 M | USA |